Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

311 Views

C4. Respiratory infections - viral

Poster Session: Respiratory Infections - Viral

(P-681) Estimated Incidence of Respiratory Syncytial Virus (RSV)-related Hospitalizations for Acute Respiratory Infections (ARIs), including Community Acquired Pneumonia (CAP), in Adults in Germany

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Caihua Liang, MD, PhD

Senior Director
Pfizer Inc
New York, New York, United States

Elizabeth Begier, MD, M.P.H.

Senior Director, Scientific Affairs Lead, RSV Antiviral/Adult Vaccine Program
Pfizer Vaccines
Dublin, Dublin, Ireland
LW

Liz Wang, MD; MS Biostatistics

Pfizer
New York, New York, United States
CS

Claudia Schwarz, PhD

Clinical Scientist Vaccines
RWE Platform
Vienna, Wien, Austria
LB

Lea Johanna Bayer, n/a

Pfizer Pharma GmbH
Berlin, Berlin, Germany
CV

Christof Von Eiff, n/a

Senior Medical Direktor Vaccines Germany
Pfizer Pharma gmbH
Berlin, Berlin, Germany
QL

Qing Liu, M.S.

Pfizer Inc.
Collegeville, Pennsylvania, United States
JS

Jo Southern, PhD, MSc

Pfizer Inc
London, England, United Kingdom
JV

Jeffrey T. Vietri, PhD

Director, HEOR
Pfizer, Inc.
Collegeville, Pennsylvania, United States
SU

Sonal Uppal, Ph.D.

Clinical Scientist - Senior Manager
Pfizer
Champaign, Illinois, United States
BG

Bradford D. Gessner, M.D., M.P.H.

Vice President Global Medical Lead for Respiratory Vaccines
Pfizer Biopharma Group
Collegeville, Pennsylvania, United States
CT

Christian Theilacker, MD, DTM&H

Pfizer Inc.
New York, New York, United States